approval
saveIMITREX (SUMATRIPTAN SUCCINATE) — FDA approval
community read0 votes
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalIMITREX (SUMATRIPTAN) — FDA approvalDec 9, 2025 · 299d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalDec 9, 2025 · 299d ago
- approvalSUMATRIPTAN SUCCINATE — FDA approvalNov 6, 2025 · 332d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalDec 20, 2021 · 1749d ago
- approvalIMITREX (SUMATRIPTAN SUCCINATE) — FDA approvalMar 23, 2021 · 2021d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalMar 23, 2021 · 2021d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalJul 17, 2018 · 3001d ago
- approvalIMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalDec 14, 2017 · 3216d ago
same company · ±60 days · 6
- approvalSUMATRIPTAN SUCCINATE: IMITREX STATDOSE (SUMATRIPTAN SUCCINATE) — FDA approvalDec 9, 2025
- approvalSUMATRIPTAN SUCCINATE: IMITREX (SUMATRIPTAN) — FDA approvalDec 9, 2025
- approvalgepotidacin mesylate: BLUJEPA (GEPOTIDACIN MESYLATE) — FDA approvalDec 11, 2025
- approvaldepemokimab: EXDENSUR (DEPEMOKIMAB-ULAA) — FDA approvalDec 16, 2025
- approvalALBUTEROL SULFATE — FDA approvalDec 1, 2025
- approvalFLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE) — FDA approvalDec 19, 2025
comments(0)
5-min edit window · permanent after that